Emergent BioSolutions Inc. (EBS) › EPS (Diluted)Emergent BioSolutions Inc. (EBS) — EPS (Diluted)Annual figures by period end, from SEC filings.2009-12-31: $0.992010-12-31: $1.592011-12-31: $0.642012-12-31: $0.652013-12-31: $0.852014-12-31: $0.882015-12-31: $1.412016-12-31: $1.132017-12-31: $1.712018-12-31: $1.222019-12-31: $1.042020-12-31: $5.682021-12-31: $4.062022-12-31: $-4.222023-12-31: $-14.852024-12-31: $-3.602025-12-31: $0.93$0.932009-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$0.93—2026-02-27From 2025-01-012024-12-31$-3.60—2026-02-27From 2024-01-012023-12-31$-14.85—2026-02-27From 2023-01-012022-12-31$-4.22-203.9%2025-03-04From 2022-01-012021-12-31$4.06-28.5%2024-03-08From 2021-01-012020-12-31$5.68+446.2%2023-12-11From 2020-01-012019-12-31$1.04-14.8%2022-02-25From 2019-01-012018-12-31$1.22-28.7%2021-02-19From 2018-01-012017-12-31$1.71+51.3%2020-02-25From 2017-01-012016-12-31$1.13-19.9%2019-02-22From 2016-01-012015-12-31$1.41+60.2%2018-02-23From 2015-01-012014-12-31$0.88+3.5%2017-02-28From 2014-01-012013-12-31$0.85+30.8%2016-02-29From 2013-01-012012-12-31$0.65+1.6%2015-03-09From 2012-01-012011-12-31$0.64-59.7%2014-03-10From 2011-01-012010-12-31$1.59+60.6%2013-03-08From 2010-01-012009-12-31$0.99—2012-03-09From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)